NY Academy of Sciences reveals how scientists plan to combat bioterrorism & deadly pathogens
Main Category: Bio-terrorism / TerrorismArticle Date: 15 Apr 2005 - 0:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Smallpox, anthrax, dengue, plague, hantaviruses, and lassa fever --diseases that many thought had been eliminated, or at least found only in certain parts of the world -- have the potential to re-emerge and spread. Some may even become weapons in the hands of terrorists.
To combat the growing threat of bioterrorism and emerging infectious diseases, eight Regional Centers of Excellence (RCEs) for Biodefense and Emerging Infectious Diseases Research were recently established by the National Institutes of Health (NIH) and the National Allergy and Infectious Diseases (NIAID). These centers have inaugurated the Trans-RCE Biodefense Seminars. This 13-part lecture series uses video and web conferencing to present information on major pathogens for clinical and basic research professionals (including graduate students, laboratory and hospital staff) at participating institutions, and, through the Academy's eBriefings, to scientists worldwide.
The lecture series, which runs through Spring 2005, forms the basis for the Academy's latest eBriefing, Biodefense: Risk, Reality and Solutions: the Trans-RCE Biodefense Seminars (www.nyas.org/biodef/ ). The first lectures focus on smallpox and anthrax from both clinical and research perspectives. Dr. Gregory Poland of the Mayo Clinic provides the introduction.
Future reports will feature the latest information on dengue, plague, lassa fever, and hantaviruses. Highlights include vaccine development, diagnostics, therapeutics, and public health approaches to fighting emerging infectious diseases.
Each report provides video and audio files as well as comprehensive coverage of the lecture. This multimedia eBriefing includes:
-- Overview of the NIAID-sponsored series
-- Bulleted highlights and complete journalist's reports on presentations by experts in the field
-- Chapterized, searchable audio presentations, synchronized with speakers' slides
-- Links to relevant web sites, books, journal articles, and other resources
-- Cross-referenced articles from the Academy about bioterrorism and emerging infectious diseases
-- Speaker bios
Since July 2003, with its inaugural eBriefing on promising new drugs for autism, the Academy's eBriefings site at www.nyas.org has proven to be a vital source for thousands of people around the world eager to find out the latest news and research on topics such as diabetes, AIDS, RNAi machinery, vitamin E and health, and other cutting-edge issues. Sponsored by the Academy, one of the oldest and most respected scientific institutions in the United States, eBriefings offer a compendium of what today's researchers worldwide are most concerned about.
Founded in 1817, the New York Academy of Sciences is an independent nonprofit organization of more than 22,000 members worldwide dedicated to advancing science and building communities.
Contact: Jennifer Tang
jtang@nyas.org
212-838-0230 x257
New York Academy of Sciences
http://www.nyas.org
Visit our bio-terrorism / terrorism section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/22846.php>
APA
http://www.medicalnewstoday.com/releases/22846.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



